Changchun GenSci Pharmaceutical Company
June 16, 2025
Company Presentation
Multiline Global Biopharma
GenSci is a leading pharmaceutical company in China, with annual sales exceeding $1.5 billion USD in 2023. Building on its core strengths in pediatric and women's health, GenSci has strategically expanded its therapeutic focus into multiple high-impact areas, including endocrinology, oncology and immunology&inflammation (I&I). Leveraging its fully integrated research and development platform, GenSci is commited to advancing cutting-edge therapies that address unmet medical needs and improve patient outcomes across diverse disease landscapes.
Company HQ City:
Changchun City
Company HQ State:
Jilin Province
Company HQ Country:
China
Year Founded:
1997
Lead Product in Development:
Growth hormone
CEO
Dr Lei Jin
Development Phase of Lead Product
Multiple Products in Market
Exchange
Shenzhen Stock Exchange
Ticker
000661
When you expect your next catalyst update?
March 31st
What is your next catalyst (value inflection) update?
April, 2025
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}